373-49-9
373-49-9
Chemical Structure
Palmitoleic acid
- CAS No.: 373-49-9
- Formula:C16H30O2
- Molecular Weight:254.41
IUPAC Name: (Z)-hexadec-9-enoic acid
InChIKey: SECPZKHBENQXJG-FPLPWBNLSA-N
SMILES: CCCCCC/C=C\CCCCCCCC(O)=O
Biological Activity: Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Palmitoleic acid | 99.89% | Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Palmitoleic acid (Standard) | 98.44% | Pazopanib (Hydrochloride) (Standard) is the analytical standard of Pazopanib (Hydrochloride). This product is intended for research and analytical applications. Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Palmitoleic acid-d14 | 99.6% | Palmitoleic acid-d14 is the deuterium labeled Palmitoleic acid. Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Palmitoleic acid-d14-1 | Palmitoleic acid-d14-1 is the deuterium labeled Palmitoleic acid (HY-W011873). Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Palmitoleic acid-d13 | 99.9% | Palmitoleic acid-d13 is the deuterium labeled Palmitoleic acid. Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Palmitoleic acid-13C16 | 99.81% | Palmitoleic acid-13C16 is the 13C labeled Palmitoleic acid. Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
